Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition.

drug protocol number
42856
drug sponsor
Saudi Ajal
drug study
DICLOFENAC POTASSIUM
drug trial site
Saudi Ajal
drug status
Completed
drug phase